1. Home
  2. MRNA vs PKG Comparison

MRNA vs PKG Comparison

Compare MRNA & PKG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNA
  • PKG
  • Stock Information
  • Founded
  • MRNA 2010
  • PKG 1867
  • Country
  • MRNA United States
  • PKG United States
  • Employees
  • MRNA N/A
  • PKG N/A
  • Industry
  • MRNA Biotechnology: Biological Products (No Diagnostic Substances)
  • PKG Containers/Packaging
  • Sector
  • MRNA Health Care
  • PKG Consumer Discretionary
  • Exchange
  • MRNA Nasdaq
  • PKG Nasdaq
  • Market Cap
  • MRNA 10.6B
  • PKG 16.6B
  • IPO Year
  • MRNA 2018
  • PKG 2000
  • Fundamental
  • Price
  • MRNA $24.46
  • PKG $181.69
  • Analyst Decision
  • MRNA Hold
  • PKG Strong Buy
  • Analyst Count
  • MRNA 20
  • PKG 6
  • Target Price
  • MRNA $51.94
  • PKG $234.50
  • AVG Volume (30 Days)
  • MRNA 8.6M
  • PKG 816.2K
  • Earning Date
  • MRNA 05-01-2025
  • PKG 04-22-2025
  • Dividend Yield
  • MRNA N/A
  • PKG 2.72%
  • EPS Growth
  • MRNA N/A
  • PKG 19.48
  • EPS
  • MRNA N/A
  • PKG 9.56
  • Revenue
  • MRNA $3,177,000,000.00
  • PKG $8,544,799,999.00
  • Revenue This Year
  • MRNA N/A
  • PKG $6.99
  • Revenue Next Year
  • MRNA $22.14
  • PKG $3.46
  • P/E Ratio
  • MRNA N/A
  • PKG $19.20
  • Revenue Growth
  • MRNA N/A
  • PKG 9.47
  • 52 Week Low
  • MRNA $23.15
  • PKG $172.72
  • 52 Week High
  • MRNA $170.47
  • PKG $250.82
  • Technical
  • Relative Strength Index (RSI)
  • MRNA 42.25
  • PKG 42.06
  • Support Level
  • MRNA $23.70
  • PKG $178.30
  • Resistance Level
  • MRNA $28.52
  • PKG $184.53
  • Average True Range (ATR)
  • MRNA 1.34
  • PKG 5.15
  • MACD
  • MRNA -0.03
  • PKG 0.11
  • Stochastic Oscillator
  • MRNA 29.80
  • PKG 27.89

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About PKG Packaging Corporation of America

Packaging Corp. of America is the third-largest containerboard and corrugated packaging manufacturer in the United States. It produces over 4.5 million tons of containerboard annually. The company's share of the domestic containerboard market is roughly 10%. PCA differentiates itself from larger competitors by focusing on smaller customers and operating with a high degree of flexibility.

Share on Social Networks: